BAY81-8973

recombinant coagulation factor VIII · Bayer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BAY81-8973, covering 2016-02-17 to 2020-11-03. Get the full timeline:

Most recent: Clinical Trial Update: BAY81-8973 Pediatric Safety and Efficacy Trial [Phase 3]